Skip to content

Comparision of Virechana Karma and Erandadi Vati in Amavata(Rhematoid arthritis)

A Comparative clinical study of Virechana Karma and Erandadi Vati in the management of Amavata w.s.r. to Rheumatoid Arthritis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017572
Enrollment
30
Registered
2019-02-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Virechana with virechana yoga followed by Erandadi vati for 30 days: In group A patient will undergo Deepana Pachana with Trikatu Churna 2 gms TDS for 2-4 days followed by Snehapama wit

Sponsors

IPGT and RA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (1)Willing and able to participate in the study. (2)Patient having signs & symptoms of Amavata w.s.r Rhumatoid arthritis with fullfilling Diagnostic criteria. (3)Chronicity: less than 10 years. (4)Patient fit for Virechana Karma.

Exclusion criteria

Exclusion criteria: (1)Patients having severe systemic illness diseases like cardiac disorders, Carcinogenic condition. (2)Patients below 18 year and above 60 years. (3)Pregnant/lactating women. (4)Chronicity: more than 10 years. (5)Patient not fit for Virechana Karma. (6)Patients having Gouty arthritis.

Design outcomes

Primary

MeasureTime frame
Relief in sign and symptoms of AmavataTimepoint: after the follow up period

Secondary

MeasureTime frame
Improves quality of life of the patientTimepoint: after the follow up period

Countries

India

Contacts

Public Contactprof Anup Thakar

IPGT and RA GAU Jamnagar

anup_thakar@yahoo.com9427776660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026